SCHEMBL2586810

SCHEMBL2586810

O=C1OC2(c3ccccc31)c1ccc3cc(O)ccc3c1Oc1c2ccc2cc(O)ccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.64
MEN1 O00255 5/20 0.64
KMT2A Q03164 5/20 0.64
FTO Q9C0B1 5/20 0.64
TDP1 Q9NUW8 4/20 0.64
RECQL P46063 2/20 0.64
BLM P54132 2/20 0.64
PRMT1 Q99873 2/20 0.64
ACE2 Q9BYF1 2/20 0.64
HTT P42858 2/20 0.64
CYP2C19 P33261 2/20 0.64
HPGD P15428 1/20 0.64
SMAD3 P84022 1/20 0.64
LMNA P02545 5/20 0.60
GPR55 Q9Y2T6 2/20 0.60
POLB P06746 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
GNG2 P59768 1/20 0.60
GNB1 P62873 1/20 0.60
ALOX12 P18054 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29376609 1.00 MAPT (0.64) MAPTMEN1KMT2AFTOTDP1
SCHEMBL5270629 0.93 FTO (0.73) MAPTMEN1KMT2AFTOTDP1
SCHEMBL31110329 0.93 FTO (0.65) MAPTMEN1KMT2AFTOTDP1
SCHEMBL29362878 0.93 FTO (0.73) MAPTMEN1KMT2AFTOTDP1
SCHEMBL16281970 0.91 MAPT (0.65) MAPTMEN1KMT2AFTOTDP1
SCHEMBL29583321 0.88 FTO (0.62) MAPTMEN1KMT2AFTOTDP1
SCHEMBL21708060 0.88 FTO (0.62) MAPTMEN1KMT2AFTOTDP1
SCHEMBL5266530 0.86 FTO (0.57) MAPTMEN1KMT2AFTOTDP1
SCHEMBL29365877 0.86 FTO (0.57) MAPTMEN1KMT2AFTOTDP1
SCHEMBL5271242 0.86 FTO (0.60) MAPTMEN1KMT2AFTOTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275558-A1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-11-10 US claimed
WO-2023004400-A1 DIBENZOXANTHENE QUENCHERS, USES, AND METHODS OF PREPARATION Life Technologies Corporation (US) 2023-01-26 WO disclosed
US-20210087238-A1 CELL PENETRATING PEPTIDES AND RELATED COMPOSITIONS AND METHODS PYC Therapeutics Limited (AU) 2021-03-25 US disclosed
EP-2813892-B1 Photoresist underlayer film-forming composition and pattern forming processes SHINETSU CHEMICAL CO (JP) 2020-06-17 EP disclosed
EP-2567225-B1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS VIRGINIA TECH INTELLECTUAL PROPERTIES INC (US) 2019-10-02 EP disclosed
US-20180057516-A1 REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES APPLIED BIOSYSTEMS, LLC (US) 2018-03-01 US disclosed
US-9783560-B2 Reagents useful for synthesizing rhodamine-labeled oligonucleotides APPLIED BIOSYSTEMS, LLC (US) 2017-10-10 US disclosed
US-20160223558-A1 ANALYTE DETECTION USING NEAR-INFRARED FLUOROPHORES PORTLAND STATE UNIVERSITY (US) 2016-08-04 US disclosed
US-9250246-B2 Near-infrared fluorescent dyes with large stokes shifts PORTLAND STATE UNIVERSITY (US) 2016-02-02 US disclosed
US-9136121-B2 Underlayer film-forming composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-09-15 US disclosed
US-20110275558-A1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-11-10 US disclosed
US-20110275558-A1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-11-10 US disclosed
US-20110275558-A1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-11-10 US disclosed
US-20100051826-A1 Fluorescent Xanthenes and White Light Fluorophores BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2010-03-04 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed
WO-2009121247-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 WO disclosed
US-20080071070-A1 Coupling with phosphoramidite reagent; solid phase synthesis APPLERA CORPORATION (US) 2008-03-20 US disclosed
WO-2007115265-A9 REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES APPLERA CORP (US) 2007-11-29 WO disclosed
WO-2007115265-A2 REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES APPLIED BIOSYSTEMS INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES ROS1, LPO, HMOX1 MAPT 4349/4885MEN1 4478/4885KMT2A 3345/4885
US-20100051826-A1 Fluorescent Xanthenes and White Light Fluorophores XPOT, XPO6, XPO7 MAPT 343/4885MEN1 1318/4885KMT2A 4450/4885
US-20160223558-A1 ANALYTE DETECTION USING NEAR-INFRARED FLUOROPHORES BLVRB, CBR3, AKR7A2 MAPT 4472/4885MEN1 3653/4885KMT2A 2373/4885
US-20080071070-A1 Coupling with phosphoramidite reagent; solid phase synthesis RTCB, RNGTT, PHAX MAPT 2656/4885MEN1 2877/4885KMT2A 2455/4885
US-20210087238-A1 CELL PENETRATING PEPTIDES AND RELATED COMPOSITIONS AND METHODS VIP, IAPP, LNPEP MAPT 2566/4885MEN1 2738/4885KMT2A 4816/4885
US-20110275558-A1 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS LANCL2, ACSL1, LANCL1 MAPT 4166/4885MEN1 4389/4885KMT2A 4112/4885
US-20180057516-A1 REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES RTCB, RRM2B, SNRPE MAPT 3503/4885MEN1 3967/4885KMT2A 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.